-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
March 01, 2012 - for development of exenatide, leaving sole development
responsibility to Amylin Pharmaceuticals. … No major
hypoglycemia events occurred.
47
In July 2011, Amylin Pharmaceuticals, Eli Lilly, and … Drugs Future 2008;33(9):745-51.
74. … Selected pharmaceuticals in
late stage U.S. and E.U. development or
registration. … The Woodlands (TX):
Lexicon Pharmaceuticals; [accessed 2011
May 23]. [1 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
April 08, 2014 - Comparator(s): Systemic (enteral) medical therapy using corticosteroids,
medical therapy using cytostatic drugs … infantile hemangioma as compared to other medical interventions, including
corticosteroids, cytostatic drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
June 01, 2015 - (Morrisville, NC), a
subsidiary of Valeant Pharmaceuticals International, Inc. … Raleigh (NC): Salix
Pharmaceuticals, Inc. 2014 Mar. 19 p.
5. … Raleigh (NC): Salix Pharmaceuticals,
Ltd.; 2014 Oct 21 [accessed 2015 Feb 11]. [5 p]. … Salix Pharmaceuticals, Inc. … Raliegh (NC): Salix
Pharmaceuticals, Inc.; 2015 May. 7 p.
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - ORIGINAL ARTICLE
Assessment of Adherence to and Persistence on
Disease-Modifying Antirheumatic Drugs … Griffin, MD, MPH*§¶
Objective: Biologic disease-modifying antirheumatic drugs (DMARDs)
are efficacious … The discontinuation of
either of the drugs determined the end of the episode. … The impact of non-compliance
on the cost-effectiveness of pharmaceuticals: a review of the literature … New drugs for rheumatoid arthritis. N Engl J Med.
2004;350:2167–2179.
43.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_disposition-comments.pdf
March 01, 2012 - This is seldom an issue for antiepileptic drugs unless they are
given intraveneously. … However, when we looked at the
newer drugs actually compared, there are only
but a few newer drugs … Each of these properties clearly impacts the
effective selection and use of these drugs. … The problem of
pharmacokinetic interactions of other drugs with
antiepileptic drugs is important to … -
lowering drugs.
-
effectivehealthcare.ahrq.gov/products/antipsychotics-adults/research-protocol
December 01, 2010 - New drugs for the treatment of schizophourenic patients. … Developing novel antipsychotic drugs: strategies and goals. … Curr Opin CPNS Invest Drugs 2000;2:25-39.
Dawkins K, Lieberman JA, Lebowitz BD, et al. … Effectiveness of antipsychotic drugs in patients with chouronic Schizophrenia. … Comparative effectiveness of antipsychotic drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - Antipsychotic drugs, neurotransmitters, and Schizophrenia. … New drugs for the treatment of schizophourenic patients. … Developing novel antipsychotic
drugs: strategies and goals. … Effectiveness of antipsychotic drugs in
patients with chouronic Schizophrenia. … Comparative effectiveness of antipsychotic drugs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
January 01, 2011 - The nominator is also concerned with
adverse side effects of pharmaceuticals used to treat fibromyalgia … (e.g., cyclobenzaprine); simple analgesics; opioid analgesics (e.g.,
tramadol); anti-inflammatory drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
October 01, 2011 - work loss.3, 4
Common oral medications for
osteoarthritis include nonsteroidal anti-
inflammatory drugs … Food and Drug Administration
(FDA) as pharmaceuticals, including
glucosamine and chondroitin.5 Opioid … In addition, benefits and
harms may vary for individual drugs within
a class. … Non-steroidal anti-
inflammatory drugs. … Non-
steroidal anti-inflammatory drugs for low-back pain.
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
May 24, 2017 - Newly approved drugs and those under review by the FDA are described in Section B (see Table 1) above … Few data are available on efficacy for these drugs; even less is known about how their effectiveness … and harms compared with that of existing drugs. … What has Changed
New drugs: Additional clinical trials of three biosimilar drugs and a tsDMARD (an … Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/s58.pdf
October 01, 2007 - powerful and under-used resource for health services
research on the use and outcomes of prescription drugs … Key Words: Medicaid, prescription drugs, methodology, claims,
outcomes, adherence
(Med Care 2007;45: … Whereas participants in
randomized clinical trials (RCTs) of drugs sometimes fail to
represent the full … Examination of which beneficiaries use which drugs is simply a starting point; further
insight can be … while hospitalized, over-
the-counter drugs, and nonformulary drugs purchased out-of-
pocket.28
Many
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_2012-12-11.pdf
January 01, 2012 - In the health care sector, horizon
scanning pertains to identifying new (and new uses of existing) pharmaceuticals … Combination phentermine-topiramate (Qsymia®, Vivus, Inc., Mountain View, CA)
Lorcaserin (Belviq®, Arena Pharmaceuticals … Phentermine-topiramate is a controlled-release formulation
of two separate FDA-approved drugs. … Arena Pharmaceuticals and Eisai announce FDA
approval of Belviq (lorcaserin HCl) for chronic
weight … San Diego
(CA): Arena Pharmaceuticals; 2012 Jun 27
[accessed 2012 Jul 5]. [4 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/11_pepticulcer_potential_high_impact_june_2012.pdf
January 01, 2012 - For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the four topics for which (1) preliminary phase III data for drugs and … Most
research activity in this priority area is focusing on drugs and biologics for irritable bowel … Curr
Opin Investig Drugs 2001 Apr;2(4):505-9.
PMID: 11566007
43. Tappenden K, Edelman J.
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - Coordinating Council for Comparative Effectiveness
Research, AHRQ is interested in innovations in drugs … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices,
procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … below lists the three topics for which (1) preliminary phase III or later data were
available for drugs … The experts stated oral
treprostinil could be used more frequently than other drugs to treat patients
-
effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-1/research
March 30, 2009 - Annual age-specific utilization of DMARDs, glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs … rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology. … Introduction
The treatment of rheumatoid arthritis (RA) with disease modifying anti-rheumatic drugs … Interestingly, about 10% of patients were not using any study drugs on the index dates. … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-mortality-elderly_research.pdf
March 01, 2009 - first reported higher
mortality in elderly patients taking haloperidol compared with two atypical drugs … FDA warns antipsychotic drugs
may be risky for elderly. JAMA 2005 May
25;293(20):2462.
3. … Cardiac arrest and ventricular arrhythmia in
patients taking antipsychotic drugs: cohort
study using … Antipsychotic
drugs: prolonged QTc interval, torsade de
pointes, and sudden death. … Antipsychotic drugs
in dementia: what should be made of the risks?
-
effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
January 28, 2016 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … unmet need for new antiviral drugs for treating chronic HCV
infection. … Manufacturers with the most advanced candidates include the Janssen
Pharmaceuticals unit of Johnson … It excluded 72 drugs in 2015, including Harvoni, Sovaldi, and Olysio. … Available:
http://blue.regence.com/trgmedpol/drugs/dru366
.pdf.
91.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
August 01, 2012 - they are based on
insufficient or low evidence and the broad categorization
into newer and older drugs … Comparative safety of antiepileptic drugs
during pregnancy. Neurology. 2012 May
22;78(21):1692-9. … Gastrointestinal adverse effects of
antiepileptic drugs in intractable epileptic
patients. … Assessing bioequivalence of generic
antiepilepsy drugs. … Suicidal risk and suicide attempts in
people treated with antiepileptic drugs for
epilepsy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
August 01, 2012 - they are based on
insufficient or low evidence and the broad categorization
into newer and older drugs … Comparative safety of antiepileptic drugs
during pregnancy. Neurology. 2012 May
22;78(21):1692-9. … Gastrointestinal adverse effects of
antiepileptic drugs in intractable epileptic
patients. … Assessing bioequivalence of generic
antiepilepsy drugs. … Suicidal risk and suicide attempts in
people treated with antiepileptic drugs for
epilepsy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-seniors-pneumonia_research.pdf
May 01, 2008 - period
preceding a hospitalization for depression [7], leading to the hypothesis that antidepressant drugs … Most diagnoses, drugs
prescribed ever in the past, and currently prescribed drugs examined were substantially … range of potential signals to be further
tested, did not measure actual exposure to antidepressant drugs … Risk of community-
acquired pneumonia and use of gastric acid-
suppressive drugs. … 536 (4.5) 636 (1.3) 2.24 (1.97 to 2.54)
suicidal ideation 7 (0.1) 19 (0.0) 1.98 (0.78 to 5.07)
drugs